A Phase I/II Study of Oral Calcitriol in Combination with Ketoconazole in Androgen Independent Prostate Cancer
Description: 

This study is being done to determine the frequency with which objective reductions in the manifestation of prostate cancer occur with the therapy of calcitriol in combination with the drug ketconazole and the drug hydrocortisone.

Study Number: 

I 68905

Phase: 
II
Principal Investigator: 
ClinicalTrials.Gov ID: 
NCT00536991

To inquire about participating in these studies, call 1-877-ASK-RPCI (1-877-275-7724) or e-mail askrpci@roswellpark.org.